Patent US6333347B1 successfully refreshed from Google Patents.
← Back to Patent Explorer
US6333347B1 Expired / Lapsed US ⏱️ 0.0 years remaining

Intrapericardial delivery of anti-microtubule agents

Assignee: IPXMEDICAL LLC
•
Filing: 2000-01-28
•
Granted: 2001-12-25
•
Expires: 2020-01-28
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Methods and compositions are provided for intra-pericardial administration of anti-microtubule agents, suitable for use in treating or preventing a variety of diseases of the pericardium, heart, or, coronary vasculature.

Inventors

  • 👤 William L. Hunter
  • 👤 Keith L. March

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 19:53
CPC Classifications
A; A61; A61K; A61K31/00; A61K31/33; A61K31/335; A61K31/337; A61P; A61P9/00

Claims Analysis

Total Claims: 7
Claim 1
Independent Claim 38 words
A method for treating or preventing disease of the pericardium, heart, or coronary vasculature, comprising administering intrapericardially to a patient an anti-microtubule agent, such that said disease of the pericardium, heart, or coronary vasculature is treated or prevented.
Claim 2
Independent Claim 38 words
A method for treating or preventing disease of the pericardium, heart, or coronary vasculature, comprising administering intrapericardially to a patient an anti-microtubule agent, such that said disease of the pericardium, heart, or coronary vasculature is treated or prevented.
Claim 3
Dependent Claim 18 words
The method according to claim 1 wherein said anti-microtubule agent is paclitaxel, or an analogue or derivative thereof.
Claim 4
Dependent Claim 12 words
The method according to claim 1 wherein said disease is intimal hyperplasia.
Claim 5
Dependent Claim 14 words
The method according to claim 1 wherein said anti-microtubule agent further comprises a polymer.
Claim 6
Dependent Claim 12 words
The method according to claim 4 wherein said polymer is poly-lactic acid.
Claim 7
Dependent Claim 12 words
The method according to claim 4 wherein said polymer is hyaluronic acid.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2004-12-24 2005-06-25 2005-12-25 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2008-12-24 2009-06-25 2009-12-25 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2012-12-24 2013-06-25 2013-12-25 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag